Disc Medicine Announces $90 Million Series B Financing to Advance Portfolio of Clinical-Stage Therapies for Hematologic Diseases

from Venture Capital Access Online: Latest Venture Capital and Private Equity News https://ift.tt/3BDYD0g
via IFTTT